Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Mogamulizumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Poteligeo

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Poteligeo

    Mogamulizumab

    arrow
    BioFlorida Conference
    Not Confirmed

    Brand Name : Poteligeo

    Japan
    arrow
    BioFlorida Conference
    Not Confirmed

    Kyowa Kirin

    Mogamulizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 129

    2019 Revenue in Millions : 121

    Growth (%) : 6

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Poteligeo

    Mogamulizumab

    arrow
    BioFlorida Conference
    Not Confirmed

    Brand Name : Poteligeo

    Japan
    arrow
    BioFlorida Conference
    Not Confirmed

    Kyowa Kirin

    Mogamulizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 146

    2020 Revenue in Millions : 129

    Growth (%) : 27

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Poteligeo

    Mogamulizumab

    arrow
    BioFlorida Conference
    Not Confirmed

    Brand Name : Poteligeo

    Japan
    arrow
    BioFlorida Conference
    Not Confirmed

    Kyowa Kirin

    Mogamulizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 184

    2021 Revenue in Millions : 146

    Growth (%) : 26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Poteligeo

    Mogamulizumab

    arrow
    BioFlorida Conference
    Not Confirmed

    Brand Name : Poteligeo

    Japan
    arrow
    BioFlorida Conference
    Not Confirmed

    Kyowa Kirin

    Mogamulizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2023 Revenue in Millions : 204

    2022 Revenue in Millions : 184

    Growth (%) : 25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Poteligeo

    Mogamulizumab

    arrow
    BioFlorida Conference
    Not Confirmed

    Brand Name : Poteligeo

    Japan
    arrow
    BioFlorida Conference
    Not Confirmed

    Kyowa Kirin

    Mogamulizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2017 Revenue in Millions : 18

    2016 Revenue in Millions : 18

    Growth (%) : 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Poteligeo

    Mogamulizumab

    arrow
    BioFlorida Conference
    Not Confirmed

    Brand Name : Poteligeo

    Japan
    arrow
    BioFlorida Conference
    Not Confirmed

    Kyowa Kirin

    Mogamulizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2018 Revenue in Millions : 35

    2017 Revenue in Millions : 17

    Growth (%) : 105%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Poteligeo

    Mogamulizumab

    arrow
    BioFlorida Conference
    Not Confirmed

    Brand Name : Poteligeo

    Japan
    arrow
    BioFlorida Conference
    Not Confirmed

    Kyowa Kirin

    Mogamulizumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2019 Revenue in Millions : 119

    2018 Revenue in Millions : 36

    Growth (%) : 228

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF